Stifel Maintains Buy on Amdocs, Lowers Price Target to $71

Benzinga Newsdesk www.benzinga.com Negative 56.0%

Neg 56% Neu 0% Pos 0%

Stifel analyst Shlomo Rosenbaum maintains Amdocs (NASDAQ:DOX) with a Buy and lowers the price target from $88 to $71.

Comments

No comments yet. Be the first!